FGF16 and myocardial infarction: In a MI model and under a diabetes-inducing genetic modification (db/db), FGF9 and FGF16 suppressed pro-inflammatory responses (i.e., monocyte infiltration, M1 macrophage generation differentiated from monocytes and pro-inflammatory cytokine production).